CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病预防

Abstract

Recommended Article

High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease: A Randomized Study Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes Short-Term Progression of Multiterritorial Subclinical Atherosclerosis Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop Long-term effects of intensive glucose lowering on cardiovascular outcomes Negative Risk Markers for Cardiovascular Events in the Elderly Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Original Research2021 Apr 2;128(7):908-933.

JOURNAL:Circ Res. Article Link

Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?

MS Madhur, F Elijovich, MR Alexander et al. Keywords: T-lymphocytes; autoimmunity; cytokines; dendritic cells; hypertension; immunity; inflammation

Full Text PDF